OTTAWA, Ontario–(BUSINESS WIRE)–May. 15, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals…
Session to complement Nordion’s educational portfolio for physicians
OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 10, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called “TheraSphere® Test Flight Interactive: How to Treat or Should I Treat?” at the Society for Interventional Radiologists (SIR) Annual Scientific Meeting, taking place April 13-18 in New Orleans, Louisiana…
Meetings designed to support TheraSphere® treatment growth and expansion in Europe
OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 9, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host two upcoming educational and scientific meetings to support the growth and expansion of TheraSphere® treatment in Europe…
TheraSphere.com provides unique resources and targeted information about this innovative radioembolization therapy
OTTAWA, Ontario–(BUSINESS WIRE)–Mar. 5, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources…
OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 28, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it is appointing Grant Gardiner as Senior Vice President, General Counsel & Corporate Secretary. Mr. Gardiner will serve as the Corporation’s legal officer responsible for all global legal matters, effective March 18, 2013…
Agenda includes new HCC clinical data and an update on TheraSphere® Phase III clinical trials OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 24, 2013– Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today it is hosting…
